Cagent Vascular
Developing innovative intravascular lithotripsy technology for treating calcified peripheral artery disease.
About
Cagent Vascular, Inc. is a medical device company focused on developing and commercializing innovative intravascular lithotripsy (IVL) technology. Their flagship product, the Serranator SONIC IVL System, is designed to treat calcified lesions in peripheral arteries, a common and challenging condition in patients with Critical Limb Ischemia (CLI). Teams look it up for Medical Devices, Healthcare, Biotechnology.
Frequently asked
What does Cagent Vascular do?
Cagent Vascular is a Medical Devices company that offers Hardware. Teams look it up for Healthcare, Biotechnology. It is based in Wayne, Pennsylvania, USA and was founded in 2015. Public records show $41M in total funding. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has Cagent Vascular raised?
Cagent Vascular has raised a total of $41M in funding. The most recent round on record is Series D.
Where is Cagent Vascular headquartered?
Cagent Vascular is headquartered in Wayne, Pennsylvania, USA.
When was Cagent Vascular founded?
Cagent Vascular was founded in 2015.
What industry does Cagent Vascular operate in?
Cagent Vascular operates in Medical Devices, Healthcare, Biotechnology.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.